NCT04021875

Brief Summary

This study aims to prospectively evaluate the therapeutic effects of autologous simple limbal epithelial transplantation for patients with limbal stem cell deficiency. The change of visual acuity, quality of life and so on will be monitored before and after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

July 5, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

July 16, 2019

Status Verified

June 1, 2019

Enrollment Period

12 months

First QC Date

July 3, 2019

Last Update Submit

July 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Numbers of patients with clinical success

    Clinical success was defined as a completely epithelized, avascular, stable corneal surface. Failure was defined as a recurrence of fibrovascular pannus encroaching on the central cornea, frequent epithelial breakdown or persistent epithelial defects. Kaplan-Meier survival curves were constructed and survival probability calculated using the SPSS software for statistical computing. Focal recurrences of pannus not progressing to the central cornea were not considered as failures and were evaluated separately.

    6 months

Secondary Outcomes (1)

  • Visual acuity change

    6 months

Eligibility Criteria

Age10 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with limbal stem cell deficiency

You may qualify if:

  • Age 10-90 years old
  • The lesion eye has at least grade 2 limbal stem cell deficiency
  • The lesion eye has limbal stem cell deficiency causing recurrent corneal erosion and neovascularization ingrowth
  • The symptoms last for at least 6 months and do not improve with medication

You may not qualify if:

  • Symptoms improve spontaneously or under medication
  • Someone who can not be examined regularly after the operation
  • Someone with poor prognosis
  • Severe lagophthalmos or trichiasis that has not been corrected
  • Ocular infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan, Republic of China, 10002, Taiwan

RECRUITING

Related Publications (3)

  • Sangwan VS, Basu S, MacNeil S, Balasubramanian D. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency. Br J Ophthalmol. 2012 Jul;96(7):931-4. doi: 10.1136/bjophthalmol-2011-301164. Epub 2012 Feb 10.

  • Vazirani J, Ali MH, Sharma N, Gupta N, Mittal V, Atallah M, Amescua G, Chowdhury T, Abdala-Figuerola A, Ramirez-Miranda A, Navas A, Graue-Hernandez EO, Chodosh J. Autologous simple limbal epithelial transplantation for unilateral limbal stem cell deficiency: multicentre results. Br J Ophthalmol. 2016 Oct;100(10):1416-20. doi: 10.1136/bjophthalmol-2015-307348. Epub 2016 Jan 27.

  • Borroni D, Wowra B, Romano V, Boyadzhieva M, Ponzin D, Ferrari S, Ahmad S, Parekh M. Simple limbal epithelial transplantation: a review on current approach and future directions. Surv Ophthalmol. 2018 Nov-Dec;63(6):869-874. doi: 10.1016/j.survophthal.2018.05.003. Epub 2018 May 22.

MeSH Terms

Conditions

Limbal Stem Cell Deficiency

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Wei-Li Chen, phD

    National Taiwan University Hospital

    STUDY CHAIR

Central Study Contacts

Wei-Li Chen, phD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 16, 2019

Study Start

July 5, 2019

Primary Completion

July 1, 2020

Study Completion

July 1, 2025

Last Updated

July 16, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

No IPD sharing

Locations